Search
-
Ipsos Update - May 2020
This month’s edition of Ipsos Update brings you a round-up of the latest research and analysis from Ipsos teams around the world.
-
Work, employability and retirement, a French paradox
Like most people around the world, French workers value their job and find meaning in it but they suspect they won’t be able to work as long as they would like to.
-
Understanding the Coronavirus Crisis #4 [Webinar recording]
This fourth edition sees us bring together our latest research on coronavirus and draws on our surveys, social media monitoring and the analysis of our teams around the world.
-
Coronavirus dominates global worries
COVID-19 overtakes all other issues in Ipsos’ What Worries the World survey with the highest level of concern recorded for any category since the series began.
-
High income households more likely to want business to reopen even if COVID-19 isn’t contained
Two in 5 high income respondents want economy to reopen compared to a third of low-income.
-
How Ipsos are already planning for retail, office and public space recovery
As we approach the ‘new normal’ we have been working hard to develop solutions to maximize social distancing awareness. Naturally this applies to all locations; retailers, offices, warehouses, public places and transport hubs to name just a few. For many years we have been installing our Occupancy solution however, given the current situation, we have developed this further. The Social Distancing Live Occupancy Solution was designed for essential retailers in mind but now, as we approach life 2 meters apart, this solution is being implemented in office buildings as well as retailers.
-
Leading pharmaceutical brands demonstrating leadership
As Covid-19 continues to disrupt traditional care norms, major pharma products have an unprecedented opportunity to define new market dynamics and demonstrate population health leadership.
-
Evaluating and adapting your soon-to-launch pharma strategy
Covid-19 has greatly disrupted the channels of communication between healthcare professionals and pharma manufacturers, especially those preparing for a product launch.
-
Assessing the risk profile of recently launched drugs
Manufacturers of the 48 launched products since January 2019 are facing a unique challenge in the current Covid-19 market.